Delivery Order SPE2DB22D3501-SPE2DB25FXK51
- Not listed
- The Defense Logistics Agency awarded a $49,131.24 delivery order to AmerisourceBergen Drug Corp for the supply of JEVTANA (cabazitaxel) 60 mg/1.5 mL kits on July 22, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. JEVTANA is a chemotherapy agent used in oncology treatment, and this delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of JEVTANA 60 mg/1.5 ml kits, valued at approximately $49.1k with a firm fixed price structure. This non-set-aside, competitively awarded delivery order is scheduled for completion by June 3, 2025, with performance to be executed at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. JEVTANA is a prescription oncology medication used in the treatment of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JEVTANA 60 MG/1.5 ML KIT 1.5ML, a pharmaceutical product, with a ceiling value of $16,377.08 and a completion date of January 30, 2025. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JEVTANA 60 MG/1.5 ML KIT 1.5ML, a medical product, with a ceiling value of $30,006.73 and a completion date of December 1, 2022. The contract is a Firm Fixed Price (FFP) delivery order, and is not set aside for any specific business category. AmerisourceBergen Drug Corp...
- The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,475.96 firm fixed-price delivery order contract is to supply the specialty medication JEVTANA 60 MG/1.5 ML KIT 1.5ML. The contract has an ultimate completion date of February 7, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- The Defense Logistics Agency Troop Support Medical awarded a $14,338.92 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division for the provision of 4562316327 JEVTANA 60 MG/1.5 ML KIT 1.5ML. Place of performance will be in Conshohocken, Pennsylvania, with work beginning on September 26, 2023 and concluding on October 18, 2023. As the Defense Logistics Agency supports the procurement of medical supplies and pharmaceuticals for the U.S. Department of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,188.54 firm fixed-price delivery order is for the supply of JEVTANA 60 MG/1.5 ML KIT 1.5ML, a pharmaceutical product, with a period of performance through March 2025. The award is not associated with a set-aside program. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product Jevtana 60 mg/1.5 ml kit. The award ceiling value is $14,737.98 and the ultimate completion date is April 22, 2024. This appears to be a one-off contract order and not part of a larger contract vehicle. No set-aside designation was used....
- The Defense Logistics Agency Troop Support Medical awarded a $14,338.92 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of JEVTANA 60 MG/1.5 ML kits. Performance will take place in Conshohocken, Pennsylvania over approximately three weeks concluding in early October. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corporation, will deliver the chemotherapy drug to support the DLA's provision of medical supplies to the Department of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $29,475.96 fixed-price delivery order is for the pharmaceutical product Jevtana 60 mg/1.5 ml kit. The award is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXK51Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,377.08 to AmerisourceBergen Drug Corp for JEVTANA 60 mg/1.5 mL kits on September 18, 2025, with an ultimate completion date of October 9, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. JEVTANA (cabazitaxel) is a chemotherapy medication used in cancer treatment, reflecting the pharmaceutical supply requirements of federal military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The company's consistent receipt of competitively awarded contracts demonstrates its capability to meet rigorous federal procurement standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.4k | 9/18/25 |